Skip to main content
Top
Published in: Journal of Immigrant and Minority Health 3/2015

01-06-2015 | Original paper

Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study

Authors: Jane R. Montealegre, Patricia D. Mullen, Maria L. Jibaja-Weiss, Maria M. Vargas Mendez, Michael E. Scheurer

Published in: Journal of Immigrant and Minority Health | Issue 3/2015

Login to get access

Abstract

Here we evaluate the acceptability and feasibility of self-sample human papillomavirus (HPV) testing (self-HPV) among a sample of predominantly Mexican immigrant women who never or sporadically attend for Pap testing. Immigrant women who had not had a Pap test in the past 3 years (n = 100) were recruited. Participants self-collected a cervical sample for HPV testing. High-risk (HR) HPV-positive women were referred for clinical follow-up. Acceptability of self-HPV was high, with 99 % reporting that they would be willing to use self-HPV regularly. Nineteen women (19 %) tested positive for HR–HPV. Of these, 50 % obtained clinical follow-up within 3 months. For those who did not, the primary barrier to follow-up was difficulty obtaining healthcare coverage. In conclusion, self-HPV is highly acceptable to Mexican immigrant women who otherwise do not attend for Pap testing. While the approach addresses critical barriers to primary screening, questions remain as to whether uninsured HR–HPV positive women are able to attend for clinical follow-up.
Literature
1.
go back to reference Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998–2003. Cancer. 2008;113(10 Suppl):2855–64.CrossRefPubMed Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998–2003. Cancer. 2008;113(10 Suppl):2855–64.CrossRefPubMed
2.
go back to reference Centers for Disease Control and Prevention (CDC). Invasive cervical cancer among Hispanic and non-Hispanic women–United States, 1992–1999. MMWR Morb Mortal Wkly Rep. 2002;51(47):1067–70. Centers for Disease Control and Prevention (CDC). Invasive cervical cancer among Hispanic and non-Hispanic women–United States, 1992–1999. MMWR Morb Mortal Wkly Rep. 2002;51(47):1067–70.
3.
go back to reference Horner MJ, Altekruse SF, Zou Z, Wideroff L, Katki HA, Stinchcomb DG. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(4):591–9.CrossRefPubMedCentralPubMed Horner MJ, Altekruse SF, Zou Z, Wideroff L, Katki HA, Stinchcomb DG. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(4):591–9.CrossRefPubMedCentralPubMed
6.
go back to reference Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME. Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of surveillance, epidemiology, and end results data. Cancer Causes Control. 2013;24(11):1985–94.CrossRefPubMedCentralPubMed Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME. Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of surveillance, epidemiology, and end results data. Cancer Causes Control. 2013;24(11):1985–94.CrossRefPubMedCentralPubMed
7.
go back to reference Schur CL, Bernstein AB, Berk ML. The importance of distinguishing Hispanic subpopulations in the use of medical care. Med Care. 1987;25(7):627–41.CrossRefPubMed Schur CL, Bernstein AB, Berk ML. The importance of distinguishing Hispanic subpopulations in the use of medical care. Med Care. 1987;25(7):627–41.CrossRefPubMed
8.
go back to reference Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12):1028–35.CrossRefPubMedCentralPubMed Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12):1028–35.CrossRefPubMedCentralPubMed
9.
go back to reference Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int J Epidemiol. 2006;35(4):903–19.CrossRefPubMed Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int J Epidemiol. 2006;35(4):903–19.CrossRefPubMed
11.
go back to reference Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRefPubMed Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRefPubMed
12.
go back to reference Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249–57.CrossRefPubMed Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249–57.CrossRefPubMed
13.
go back to reference Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579–88.CrossRefPubMed Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579–88.CrossRefPubMed
14.
go back to reference Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94.CrossRefPubMed Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94.CrossRefPubMed
15.
go back to reference Anttila A, Kotaniemi-Talonen L, Leinonen M, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ. 2010;340:1804.CrossRef Anttila A, Kotaniemi-Talonen L, Leinonen M, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ. 2010;340:1804.CrossRef
16.
go back to reference Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst. 2009;101(23):1612–23.CrossRefPubMed Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst. 2009;101(23):1612–23.CrossRefPubMed
18.
go back to reference Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect. 2005;81(3):207–12.CrossRefPubMedCentralPubMed Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect. 2005;81(3):207–12.CrossRefPubMedCentralPubMed
19.
go back to reference Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007;105(2):530–5.CrossRefPubMed Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007;105(2):530–5.CrossRefPubMed
20.
go back to reference Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.CrossRefPubMed Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.CrossRefPubMed
21.
go back to reference Barbee L, Kobetz E, Menard J, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control. 2010;21(3):421–31.CrossRefPubMed Barbee L, Kobetz E, Menard J, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control. 2010;21(3):421–31.CrossRefPubMed
22.
go back to reference Petignat P, Vassilakos P. Is it time to introduce hpv self-sampling for primary cervical cancer screening? J Natl Cancer Inst. 2012;104(3):166–7.CrossRefPubMed Petignat P, Vassilakos P. Is it time to introduce hpv self-sampling for primary cervical cancer screening? J Natl Cancer Inst. 2012;104(3):166–7.CrossRefPubMed
23.
go back to reference Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072–9.CrossRefPubMed Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072–9.CrossRefPubMed
24.
go back to reference Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing versus the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med. 2002;11(3):265–75.CrossRefPubMed Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing versus the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med. 2002;11(3):265–75.CrossRefPubMed
25.
go back to reference De Alba I, Anton-Culver H, Hubbell FA, et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2163–8.CrossRefPubMed De Alba I, Anton-Culver H, Hubbell FA, et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2163–8.CrossRefPubMed
26.
go back to reference Scarinci IC, Litton AG, Garces-Palacio IC, Partridege EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues. 2013;23(2):e123–30.CrossRefPubMedCentralPubMed Scarinci IC, Litton AG, Garces-Palacio IC, Partridege EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues. 2013;23(2):e123–30.CrossRefPubMedCentralPubMed
27.
go back to reference Castle PE, Rausa A, Walls T, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011;52(6):452–5.CrossRefPubMedCentralPubMed Castle PE, Rausa A, Walls T, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011;52(6):452–5.CrossRefPubMedCentralPubMed
28.
go back to reference Léniz J, Barriga MI, Lagos M, Ibanez C, Pushchel K, Ferreccio C. HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile. Salud Publica Mex. 2013;55:162–9.CrossRefPubMed Léniz J, Barriga MI, Lagos M, Ibanez C, Pushchel K, Ferreccio C. HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile. Salud Publica Mex. 2013;55:162–9.CrossRefPubMed
29.
go back to reference Trope LA, Chumworathayi B, Blumenthal PD. Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand. J Low Genit Tract Dis. 2013;17(3):315–9.CrossRefPubMed Trope LA, Chumworathayi B, Blumenthal PD. Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand. J Low Genit Tract Dis. 2013;17(3):315–9.CrossRefPubMed
30.
go back to reference Rosenbaum AJ, Gage JC, Alfaro KM, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obst. 2014;126(2):156–60.CrossRef Rosenbaum AJ, Gage JC, Alfaro KM, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obst. 2014;126(2):156–60.CrossRef
31.
go back to reference Bansil P, Wittet S, Lim JL, Winkler JL, Pail P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14(1):1–9.CrossRef Bansil P, Wittet S, Lim JL, Winkler JL, Pail P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14(1):1–9.CrossRef
32.
go back to reference Bais AG, van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120(7):1505–10.CrossRefPubMed Bais AG, van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120(7):1505–10.CrossRefPubMed
33.
go back to reference Gok M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:1040.CrossRef Gok M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:1040.CrossRef
34.
go back to reference Gok M, vab Kemenade FJ, Heideman DA, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer. 2012;130(5):1128–35.CrossRefPubMed Gok M, vab Kemenade FJ, Heideman DA, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer. 2012;130(5):1128–35.CrossRefPubMed
35.
go back to reference Sanner K, Wikstrom I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009;101(5):871–4.CrossRefPubMedCentralPubMed Sanner K, Wikstrom I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009;101(5):871–4.CrossRefPubMedCentralPubMed
36.
go back to reference Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104(2):248–54.CrossRefPubMedCentralPubMed Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104(2):248–54.CrossRefPubMedCentralPubMed
37.
go back to reference Virtanen A, Nieminen AP, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1960–9.CrossRefPubMed Virtanen A, Nieminen AP, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1960–9.CrossRefPubMed
38.
go back to reference Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening—a randomised controlled trial. Br J Cancer. 2011;104(6):915–20.CrossRefPubMedCentralPubMed Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening—a randomised controlled trial. Br J Cancer. 2011;104(6):915–20.CrossRefPubMedCentralPubMed
39.
go back to reference Piana L, Leanidri FX, Le Retraite L, Heid P, Tamalet C, Sancho-Garnier H. HPV–HR detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhone. Bull Cancer. 2011;98(7):723–31.PubMed Piana L, Leanidri FX, Le Retraite L, Heid P, Tamalet C, Sancho-Garnier H. HPV–HR detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhone. Bull Cancer. 2011;98(7):723–31.PubMed
40.
go back to reference Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337–9.CrossRefPubMedCentralPubMed Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337–9.CrossRefPubMedCentralPubMed
43.
go back to reference Selwyn BJ, Loe HD. The Valley Primary Health Review: a report of the Indigent Health Care Review Committee of the Health Planning Advisory Committee of the Lower Rio Grande Valley Development Council. 1989. Selwyn BJ, Loe HD. The Valley Primary Health Review: a report of the Indigent Health Care Review Committee of the Health Planning Advisory Committee of the Lower Rio Grande Valley Development Council. 1989.
44.
go back to reference Montealegre JR, Selwyn BJ. Healthcare coverage and use among undocumented Central American immigrant women in Houston, Texas. J Immigr Minor Health. 2014;16(2):204–10. Montealegre JR, Selwyn BJ. Healthcare coverage and use among undocumented Central American immigrant women in Houston, Texas. J Immigr Minor Health. 2014;16(2):204–10.
45.
go back to reference Shi JF, Canfell K, Lew JB, et al. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer. 2011;11:239.CrossRefPubMedCentralPubMed Shi JF, Canfell K, Lew JB, et al. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer. 2011;11:239.CrossRefPubMedCentralPubMed
46.
go back to reference Larkey L. Las mujeres saludables: reaching Latinas for breast, cervical and colorectal cancer prevention and screening. J Community Health. 2006;31(1):69–77.CrossRefPubMed Larkey L. Las mujeres saludables: reaching Latinas for breast, cervical and colorectal cancer prevention and screening. J Community Health. 2006;31(1):69–77.CrossRefPubMed
47.
go back to reference Messias DK, Parra-Medina D, Sharpe PA, Trevino L, Koskan AM, Morales-Campos D. Promotoras de Salud: roles, responsibilities, and contributions in a multisite community-based randomized controlled trial. Hisp Health Care Int. 2013;11(2):62–71.CrossRefPubMed Messias DK, Parra-Medina D, Sharpe PA, Trevino L, Koskan AM, Morales-Campos D. Promotoras de Salud: roles, responsibilities, and contributions in a multisite community-based randomized controlled trial. Hisp Health Care Int. 2013;11(2):62–71.CrossRefPubMed
48.
go back to reference Saad-Harfouche FG, Jandor L, Gage E, Thelemaque LD, Colon J, Castillo AG, Erwin DO. Esperanza y Vida: training lay health advisors and cancer survivors to promote breast and cervical cancer screening in Latinas. J Community Health. 2011;36(2):219–27.CrossRefPubMed Saad-Harfouche FG, Jandor L, Gage E, Thelemaque LD, Colon J, Castillo AG, Erwin DO. Esperanza y Vida: training lay health advisors and cancer survivors to promote breast and cervical cancer screening in Latinas. J Community Health. 2011;36(2):219–27.CrossRefPubMed
49.
go back to reference Fernandez M, Gonzales A, Tortolero-Luna G, Williams J, Saavedra-Embesi M, Chan W. Effectiveness of Cultivando la Salud: a bredast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health. 2009;99(5):936–43.CrossRefPubMedCentralPubMed Fernandez M, Gonzales A, Tortolero-Luna G, Williams J, Saavedra-Embesi M, Chan W. Effectiveness of Cultivando la Salud: a bredast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health. 2009;99(5):936–43.CrossRefPubMedCentralPubMed
50.
go back to reference Eperon I, Vassilakos P, Navarria I, et al. Randomized comparison of vaginal self-sampling by standard versus dry swabs for Human papillomavirus testing. BMC Cancer. 2013;13:353.CrossRefPubMedCentralPubMed Eperon I, Vassilakos P, Navarria I, et al. Randomized comparison of vaginal self-sampling by standard versus dry swabs for Human papillomavirus testing. BMC Cancer. 2013;13:353.CrossRefPubMedCentralPubMed
51.
go back to reference Haguenoer K, Giraudeau B, Gaudy-Graffin C, et al. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study. Gynecol Oncol. 2014;134(2):302–8.CrossRefPubMed Haguenoer K, Giraudeau B, Gaudy-Graffin C, et al. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study. Gynecol Oncol. 2014;134(2):302–8.CrossRefPubMed
52.
go back to reference Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi LF, Shen Z, Winer RL. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing. J Med Microbiol. 2012;61(11):1538–45.CrossRefPubMed Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi LF, Shen Z, Winer RL. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing. J Med Microbiol. 2012;61(11):1538–45.CrossRefPubMed
53.
go back to reference Agency for Healthcare Research and Quality (AHRQ). Healthcare innovations exchange: bilingual, culturally competent community health workers increase insurance enrollment, access to care, and self-efficacy among low-income Latinos. 2012. Agency for Healthcare Research and Quality (AHRQ). Healthcare innovations exchange: bilingual, culturally competent community health workers increase insurance enrollment, access to care, and self-efficacy among low-income Latinos. 2012.
Metadata
Title
Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study
Authors
Jane R. Montealegre
Patricia D. Mullen
Maria L. Jibaja-Weiss
Maria M. Vargas Mendez
Michael E. Scheurer
Publication date
01-06-2015
Publisher
Springer US
Published in
Journal of Immigrant and Minority Health / Issue 3/2015
Print ISSN: 1557-1912
Electronic ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-014-0125-5

Other articles of this Issue 3/2015

Journal of Immigrant and Minority Health 3/2015 Go to the issue